Melrose Industries PLC MLSPF
6.23 USD -0.21 (-3.26%)
At closeNov 4, 2026, 4:00 PM EST
6.10 Day range 6.23
5.39 52-week range 9.60
- YTD
- -19.20%
- 1 year
- -20.23%
- Market cap
- 7.76B
- EPS (ttm)
- 0.17
- P/E ratio
- 36.65
- YTD return
- -19.20%
- 1-year return
- -20.23%
- Volume
- 500
- Avg volume
- 31.28K
- Open
- 6.22
- Previous close
- 6.44
- Day's range
- 6.10 – 6.23
- 52-week range
- 5.39 – 9.60
- Earnings date
- Mar 4, 2027
5D +0.18 (+2.98%)
Next earnings
Mar 4, 2027
Expected Mar 4, 2027. Consensus EPS estimate 0.2731.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Mar 4, 2027 | Dec 30, 2026 | 0.2731 | — | — | — |
| Jul 31, 2026 | Jun 30, 2026 | 0.2278 | 0.2346 | +0.01 | +2.99% |
| Feb 27, 2026 | Dec 31, 2025 | 0.2248 | 0.2292 | 0.00 | +1.96% |
| Aug 1, 2025 | Jun 30, 2025 | 0.2002 | 0.3027 | +0.10 | +51.20% |
| Mar 3, 2025 | Dec 31, 2024 | 0.1748 | 0.02918 | -0.15 | -83.31% |
| Aug 1, 2024 | Jun 30, 2024 | 0.1403 | -0.07677 | -0.22 | -154.72% |
News
Melrose Industries Says GKN Aerospace Reaches $125 Million Settlement in Chemicals Case 
Melrose Industries: Clarity On Garden Grove Is Positive, But Uncertainties Remain 
Banks take different views on Melrose after Garden Grove claims programme 
Melrose Industries: Strong Buy Despite A Major New Risk 
Melrose Industries outlines $100 million claims programme as Garden Grove moves towards restart 
Melrose Industries PLC (MLSPF) Q2 2026 Earnings Call Transcript 
Melrose Industries H1 Earnings Call Highlights 
Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook 
Melrose shares fall 3.5% as Garden Grove incident drives £30m exceptional cost outlook 
Futura Medical gets greenlight for stronger product "Eroxon Intense"
Your note
Sign in to keep a note on MLSPF — it syncs with the Stock Master app.